Stock Updates

Today’s Top Gainers in the Market Edwards Lifesciences Corp. (NYSE:EW) from Healthcare

Today’s top gainers include the company Edwards Lifesciences Corp. (NYSE:EW) which is in the industry Medical Appliances & Equipment, gaining 1.57% today. In the last week its performance is 8.98%, and -3.70% for the past quarter. Currently, Edwards Lifesciences Corp., EW has a target price of 117.59, so today’s gain of 1.57% is a significant step towards its target price. The GAP today is therefore 0.00%.

Edwards Lifesciences Corp. (NYSE:EW), has a market cap of 22172.81, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 87.80%.

At the current price of 105.12, it has a dividend yield of *TBA, and its target price is 117.59. This is with a profit margin of 19.80%, and total debt/equity of 0.26. Edwards Lifesciences Corp. (NYSE:EW) has a P/E of 44.1, as well as a forward P/E of 31.49.

With a current EPS of 2.35, and a forecasted EPS growth for next year at 18.66%,Edwards Lifesciences Corp. (NYSE:EW) has had a EPS growth for the past five years at 19.70%. For the next five years EPS growth is projected to be 16.82%.

Performance for the year is 40.36%. Since its IPO date on 3/27/2000, the total performance to date is 31.05%.

Volume today for Edwards Lifesciences Corp. (NYSE:EW), is 555151, while its average volume is 1661.13. Whilst the total gain today was 1.57%, it did have a day high of -6.14%.

Volatility for this week has been at 2.55%, and 2.01% for the month. The 52-week low for Edwards Lifesciences Corp., EW has been 68.11%, while the 52-week-high has reached -6.14%.

Looking at its return of investments, which is 15.90%, and its return on assets is 13.40%. Edwards Lifesciences Corp. (NYSE:EW) has an operating margin of 24.70%. With a sales growth of 18.10% quarter over quarter. Bearing in mind that Edwards Lifesciences Corp., EW is in the sector Healthcare, its long-term debt/equity is 0.26, and has a current ratio of 4 and 3.2 for quick ratio.

So what is the value of Edwards Lifesciences Corp.? Well its PEG is 2.62, and the P/S is 8.53, along with a P/B of 9.59. Meanwhile it has a p/cash of 23.3.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment